ClinicalTrials.Veeva

Menu

MRCP Diagnoses EHCC Better When Combined DWI

C

China Medical University, China

Status

Completed

Conditions

Biliary Tract Neoplasm
Cholangiocarcinoma

Treatments

Device: 3T MRI

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Researching the diagnostic significance of Biliary Tract Neoplasm under combining DWI sequence with MRCP versus MRCP only separately.

Full description

The purpose of the study is to evaluate the usefulness of diffusion weighted imaging(DWI) combined with MRCP of 3.0T magnetic resonance imaging (MRI) in the evaluation of suspected malignant bile duct diseases. People with suspected Biliary Tract Neoplasm based on clinical symptoms (such as jaundice and thinness with unknown reasons) and CA-199 value raises are included.Diagnosis divided into two steps: the first one,only provide conventional MR sequences and MRCP images to make a diagnosis; the second step,provide the DWI images additionally, combining the image data before to make a diagnosis. Hypothesis is that DWI sequence should be regularly added into MRCP examination for improving diagnosis rate of Biliary Tract Neoplasm.

Enrollment

99 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent
  • Suspected Biliary Tract Neoplasm based on clinical symptoms(such as jaundice and thinness with unknown reasons)and CA-199 raises(>37U/mL)
  • No evidence of clinical symptoms or CA-199 increase by non-bile duct cancerous factors(hepatitis,cholangeitis,stones)
  • Age ≥ 16

Exclusion criteria

  • Previous Biliary Tract Neoplasm surgery
  • Contraindication for MRI (such as pacemaker or inner ear implant)
  • Claustrophobia
  • Age < 16

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

99 participants in 2 patient groups

MRCP and DWI using 3T MRI
Experimental group
Description:
MRCP and DWI using Magnetic resonance imaging(GE Signa,3.0 T )
Treatment:
Device: 3T MRI
MRCP only using 3T MRI
Experimental group
Description:
MRCP only using Magnetic resonance imaging(GE Signa,3.0 T )
Treatment:
Device: 3T MRI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems